journal article·2021-04-12

Systematic Approach to DNA Aptamer Design Using Amino Acid–Nucleic Acid Hybrids (ANHs) Targeting Thrombin

Ji Hye Yum, Takumi Ishizuka, Koyuki Fukumoto, Daisuke Hori, Hong-Liang Bao, Yan Xu, Hiroshi Sugiyama, Soyoung Park

Publisher page

Abstract

Chemical modifications of innate DNA/RNA aptamers facilitate the improvement of their function. Herein, we report our modular strategy to manipulate a thrombin-binding DNA aptamer (TBA) to improve its anticoagulation activity and binding affinity. A set of amino acid conjugates, termed amino acid-nucleic acid hybrids or ANHs, was synthesized and incorporated into a TBA loop sequences. We found that substitutions with hydrophobic amino acids in the loop region possessed significantly enhanced antithrombin activity, up to 3-fold higher than the native TBA. We investigated the correlations between thrombin-binding affinity and the features of our amino-acid conjugates using experimental techniques including circular dichroism spectroscopy, surface plasmon resonance assay, and molecular modeling. The present study demonstrates a systematic approach to aptamer design based on amino-acid characteristics, allowing the development of advanced aptamers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · DNA and Nucleic Acid Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Graduate School of Science, Kyoto University, Kitashirakawa-oiwakecho, Sakyo-ku, Kyoto 606-8502, Japan

Department of Medical Sciences, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan

Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University, Yoshida-ushinomiyacho, Sakyo-ku, Kyoto 606-8501, Japan

Funding

National Cancer Institute · Japan Agency for Medical Research and Development · Asahi Glass Foundation · Japan Society for the Promotion of Science

References (46)

Show source-provided references
1. 10.1146/annurev.bi.64.070195.00355510.1146/annurev.bi.64.070195.003555 ↗
2. 10.1038/nature0140610.1038/nature01406 ↗
3. 10.1038/346818a010.1038/346818a0 ↗
4. 10.1126/science.220012110.1126/science.2200121 ↗
5. 10.1016/j.trac.2006.05.00710.1016/j.trac.2006.05.007 ↗
6. 10.1002/anie.20080464310.1002/anie.200804643 ↗
7. 10.1039/c2an36174d10.1039/c2an36174d ↗
8. 10.1021/cr030183i10.1021/cr030183i ↗
9. 10.1038/nchembio.27710.1038/nchembio.277 ↗
10. 10.1088/0957-4484/21/45/45510210.1088/0957-4484/21/45/455102 ↗
11. 10.1016/j.cbpa.2006.03.01510.1016/j.cbpa.2006.03.015 ↗
12. 10.1021/ac302923k10.1021/ac302923k ↗
13. 10.1038/nrd314110.1038/nrd3141 ↗
14. 10.1021/acs.analchem.5b0231210.1021/acs.analchem.5b02312 ↗
15. 10.1146/annurev.biochem.68.1.61110.1146/annurev.biochem.68.1.611 ↗
16. 10.1021/ac050165w10.1021/ac050165w ↗
17. 10.1038/nsb1296-102610.1038/nsb1296-1026 ↗
18. Tucker O. W. · Curr. Pharm. Design · 2012 · 18 · 201410.2174/138161212799958477 ↗
19. 10.3390/molecules2420378110.3390/molecules24203781 ↗
20. Nagatoishi S. · Int. Rev. Biophys. Chem. · 2011 · 2 · 129
21. 10.1039/C8CC05197F10.1039/C8CC05197F ↗
22. 10.1007/s10637-013-0045-610.1007/s10637-013-0045-6 ↗
23. 10.1016/j.ijbiomac.2019.11.11810.1016/j.ijbiomac.2019.11.118 ↗
24. 10.1073/pnas.90.8.374510.1073/pnas.90.8.3745 ↗
25. 10.1006/jmbi.1994.110510.1006/jmbi.1994.1105 ↗
26. 10.1126/science.106125910.1126/science.1061259 ↗
27. 10.1182/blood.v100.1.14810.1182/blood.v100.1.148 ↗
28. 10.1007/s11814-016-0331-z10.1007/s11814-016-0331-z ↗
29. 10.2174/09298671179718956510.2174/092986711797189565 ↗
30. 10.1093/nar/gkw135710.1093/nar/gkw1357 ↗
31. 10.1016/j.omtn.2017.12.01310.1016/j.omtn.2017.12.013 ↗
32. 10.1021/jm970434d10.1021/jm970434d ↗
33. 10.1093/nar/gkm52010.1093/nar/gkm520 ↗
34. 10.2174/13816121279995838710.2174/138161212799958387 ↗
35. 10.1111/j.1538-7836.2008.03106.x10.1111/j.1538-7836.2008.03106.x ↗
36. 10.1093/nar/gky26810.1093/nar/gky268 ↗
37. 10.1016/j.omtn.2021.01.00410.1016/j.omtn.2021.01.004 ↗
38. 10.1039/C9OB00196D10.1039/C9OB00196D ↗
39. 10.1039/D0RA01267J10.1039/D0RA01267J ↗
40. 10.1002/chem.20130157810.1002/chem.201301578 ↗
41. 10.1016/S0021-9258(17)46749-410.1016/S0021-9258(17)46749-4 ↗
42. 10.1016/j.biochi.2011.03.01310.1016/j.biochi.2011.03.013 ↗
43. Langdell R. D. · J. Lab. Clinic. Med. · 1953 · 41 · 637
44. 10.1021/acs.jmedchem.0c0171110.1021/acs.jmedchem.0c01711 ↗
45. 10.1126/science.237492610.1126/science.2374926 ↗
46. 10.1111/j.1538-7836.2005.01363.x10.1111/j.1538-7836.2005.01363.x ↗